chondroitin-sulfates has been researched along with Polycystic-Kidney-Diseases* in 2 studies
2 other study(ies) available for chondroitin-sulfates and Polycystic-Kidney-Diseases
Article | Year |
---|---|
Basement membrane chondroitin sulfate proteoglycan alterations in a rat model of polycystic kidney disease.
Alterations in basement membrane components, notably proteoglycans, in a rat model of polycystic kidney disease have been investigated. Rats were fed phenol II (2-amino-4-hydroxyphenyl-5-phenyl thiazole) for 4 days and then changed to normal diet for a 7-day recovery period. Marked dilation of distal tubules and collecting ducts was observed by 4 days with phenol II treatment, but the morphology returned to normal after 7 days of subsequent normal diet. Staining of tissue sections with two mouse monoclonal antibodies to a recently described basement membrane chondroitin sulfate proteoglycan (BM-CSPG) core protein was markedly diminished in the basement membranes of dilated cystic tubules. Reduction in staining was evident as early as 2 days. During recovery, BM-CSPG increased in tubular basement membranes and returned to normal after 7 days. Staining with a polyclonal antibody to chondroitin sulfate chains confirmed these changes in cystic tubule basement membranes. During the recovery stage, interstitial chondroitin sulfate (representing a CSPG other than BM-CSPG) was greatly increased around these tubules, along with the glycoprotein fibronectin. Staining with antibody to a basement membrane heparan sulfate proteoglycan core protein related to perlecan did not diminish but rather stained affected tubules intensely, whereas laminin, on the other hand, was apparently diminished in the basement membranes of the cystic tubules. Type IV collagen staining did not change through disease onset or recovery. These results suggest that BM-CSPG, which was rapidly altered in distribution through the onset and recovery phases, may be a sensitive marker of the cystic state, and in addition, the expression of basement membrane proteoglycans may be specifically and separately regulated in this disease. Topics: Aging; Animals; Basement Membrane; Chondroitin Sulfates; Collagen; Disease Models, Animal; Fibronectins; Fluorescent Antibody Technique; Kidney Tubules; Laminin; Male; Phenols; Polycystic Kidney Diseases; Rats; Rats, Sprague-Dawley; Staining and Labeling | 1994 |
Altered synthesis of proteoglycans by cyst-derived cells from autosomal-dominant polycystic kidneys.
Normal human renal epithelial cells (NK) and cells from cysts of autosomal-dominant polycystic kidneys (ADPKD) were radiolabeled with [35S]sulfate. A two- to three-fold decrease in the radioactivity incorporated into the proteoglycan (PG) fraction, as ascertained by tissue autoradiography and biochemical techniques, was observed in the ADPKD group. In subconfluent NK cells, PGs eluted as two peaks with different proportions of chondroitin sulfate (CS) and heparan sulfate (HS) in the cellular and media fractions. In the confluent stage, only a single major peak in the media and matrix fractions was seen and had variable proportions of CS and HS. In subconfluent ADPKD monolayers, cellular PGs eluted as two peaks, with the major peak of higher molecular weight compared with NK cells. In confluent stage, there was a single PG peak of a relatively higher molecular weight, with a variable increase in the proportions of CS vs. HS and lower charge-density characteristics. These findings indicate that size and species of PGs vary during subconfluent and confluent stages of culture and elucidate a defect in the biosynthesis of PGs in human ADPKD cells. Topics: Autoradiography; Chondroitin Sulfates; Genes, Dominant; Heparitin Sulfate; Humans; Killer Cells, Natural; Polycystic Kidney Diseases; Precipitin Tests; Proteoglycans; Reference Values | 1992 |